In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biotechnology
ArQule announced on Friday that it was strengthening its management team with the addition of two new senior vice presidents, former Citibank banking director Marc Schegerin and Shirish Hirani, a longstanding VP of drug development at Ariad Pharmaceuticals. 25 May 2018
Pharmaceutical
US drugmaker Eli Lilly is looking for a new head in one of its key therapy areas after the current incumbent announced her retirement. 24 May 2018
Biotechnology
Norbert Bischofberger has been named chief executive of Kronos Bio, one of the portfolio companies of venture capital firm and merchant bank Two River. 24 May 2018
Biotechnology
AmideBio, a privately held US biotech company, has announced that Dr Pawel Fludzinski has joined the company as its new chief executive. 17 May 2018
Biotechnology
Sensei Biotherapeutics, a privately-held company known as Panacea Pharmaceuticals until earlier this year, has announced the appointment of John Celebi as chief executive as the company seeks to push forward with its lead cancer vaccine. 16 May 2018
Biotechnology
Cancer immunotherapy firm OncoQuest has appointed industry veteran Dr Eliel Bayever as chief medical officer. 14 May 2018
Pharmaceutical
UK-based drugmaker GlaxoSmithKline has announced that its chief financial officer Simon Dingemans is to retire. 10 May 2018
Biotechnology
Horizon Discovery’s announcement on the identity of its new chief executive on Monday has been followed on Tuesday by a major drop in the share price of the gene editing company. 9 May 2018
Pharmaceutical
French independent pharma company Pierre Fabre has named Eric Ducournau as its new chief executive, taking over from Bertrand Parmentier who has announced his retirement. 7 May 2018
Pharmaceutical
US pharma major Eli Lilly today announced that Leena Gandhi, a prestigious thoracic oncologist with a focus on immunotherapy and early drug development, will join Lilly Oncology on June 25, 2018 to lead immuno-oncology medical development. 2 May 2018
Pharmaceutical
Grünenthal has announced that Philip Just Larsen is to join the company chief scientific officer (CSO) and member of the corporate executive board. 30 April 2018
Pharmaceutical
The British and Irish arm of Japanese pharma titan Takeda has announced the promotion of Jon Neal to the role of managing director. 27 April 2018
Biotechnology
Omeicos Opthalmics, a subsidiary of German biotech Omeicos Therapeutics, has named Alexander Gebauer as its first chief executive. 27 April 2018
Biotechnology
UK biotech firm Redx Pharma today announced the appointment of Lisa Anson as chief executive and to its board of directors 24 April 2018
Pharmaceutical
Danish specialty pharma company Xellia Pharmaceuticals has named the leader of its oncoming assault on the US market. 23 April 2018
Generics
German drugmaker Stada Arzneimittel has snapped up senior executives from Sandoz, Biogen and Pfizer to be part of its management team. 20 April 2018
Pharmaceutical
A month after US healthcare giant Johnson & Johnson announced that its chief financial officer (CFO) Dominic Caruso was to retire after 12 years in the role and Takeda's finance boss left his job with the Japanese firm, France’s biggest pharma company has said that it is losing its long-standing CFO. 19 April 2018
Pharmaceutical
Novartis’ Vas Narasimhan, who became chief executive of the company on February 1, has now found a replacement for his previous post as head of global drug development (GDD) and chief medical officer, naming John Tsai to the position. 19 April 2018
Pharmaceutical
GlaxoSmithKline today revealed is has appointed Kevin Sin as senior vice president and head of worldwide business development for pharmaceuticals research and development. 18 April 2018
Biotechnology
Nordic Nanovector saw its share plunge 9.66% to 4.21 euros as markets opened this mornings, after the Norway-based biotech firm revealed that its chief executive, Luigi Costa, will step down from the post by mutual agreement with the board of directors. 5 April 2018
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze